- Home
- BKNG vs BSX Comparison
BKNG vs BSX Comparison
Compare BKNG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKNG
- BSX
- Stock Information
- Founded
- BKNG 1997
- BSX 1979
- Country
- BKNG United States
- BSX United States
- Employees
- BKNG N/A
- BSX N/A
- Industry
- BKNG Transportation Services
- BSX Medical/Dental Instruments
- Sector
- BKNG Consumer Discretionary
- BSX Health Care
- Exchange
- BKNG Nasdaq
- BSX Nasdaq
- Market Cap
- BKNG 166.0B
- BSX 146.2B
- IPO Year
- BKNG 1999
- BSX 1992
- Fundamental
- Price
- BKNG $4,904.51
- BSX $98.84
- Analyst Decision
- BKNG Buy
- BSX Strong Buy
- Analyst Count
- BKNG 29
- BSX 19
- Target Price
- BKNG $6,077.86
- BSX $124.53
- AVG Volume (30 Days)
- BKNG 265.2K
- BSX 8.0M
- Earning Date
- BKNG 10-28-2025
- BSX 10-22-2025
- Dividend Yield
- BKNG 0.78%
- BSX N/A
- EPS Growth
- BKNG 5.01
- BSX 54.68
- EPS
- BKNG 153.22
- BSX 1.87
- Revenue
- BKNG $26,039,000,000.00
- BSX $19,349,000,000.00
- Revenue This Year
- BKNG $14.50
- BSX $21.04
- Revenue Next Year
- BKNG $8.98
- BSX $11.45
- P/E Ratio
- BKNG $31.97
- BSX $52.97
- Revenue Growth
- BKNG 12.96
- BSX 21.61
- 52 Week Low
- BKNG $4,096.23
- BSX $85.03
- 52 Week High
- BKNG $5,839.41
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- BKNG 34.66
- BSX 46.54
- Support Level
- BKNG $4,928.14
- BSX $98.06
- Resistance Level
- BKNG $5,279.76
- BSX $102.27
- Average True Range (ATR)
- BKNG 134.48
- BSX 1.83
- MACD
- BKNG -13.75
- BSX -0.14
- Stochastic Oscillator
- BKNG 10.39
- BSX 17.29
About BKNG Booking Holdings Inc.
Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airline tickets, rental cars, restaurant reservations, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, Rentalcars.com, Kayak, and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.